RheumaGen
Website RheumaGen is a private biotechnology company engineering a new class of therapeutic to cure major autoimmune diseases at their source. RheumaGen focuses on editing the human leukocyte antigen (HLA), or “immune gene,” to develop one-time, curative cell and gene therapies. RheumaGen is headquartered in Aurora, Colorado.







